Induction of intestinal tumours in rats by chrysazin. by Mori, H. et al.
Br. J. Cancer (1985), 52, 781-783
Short Communication
Induction of intestinal tumours in rats by chrysazin
H. Mori', S. Sugiel, K. Niwal, M. Takahashi' & K. Kawai2
Departments of'Pathology; and 2Biochemistry, Gifu University School ofMedicine, 40 Tsukasa-machi,
Gifu 500, Japan
Anthraquinones are the largest group of the
naturally occurring quinones. Both natural and
synthetic anthraquinones are widely used in medical
preparations, colourants in foods, hair dyes and
others. Chrysazin (1,8-dihydroxy-9, 10-anthracene-
dione; Figure 1) is a synthetic anthraquinone with
1, 8-dihydroxy groups like other natural anthra-
quinones such as emodin and chrysophanol which
have been demonstrated to be mutagenic (Brown,
1980; Tikkanen et al., 1983). This chemical has
been employed as an important dye material in
textile industries. Mutagenicity of chrysazin has
been reported in strains of TA1537 (Brown &
Dietrich, 1979) and TA2637 (Tikkanen et al., 1983)
of Salmonella typhimurium. We demonstrated the
genotoxicity of this compound in the hepatocyte
primary culture /DNA repair test (Mori et al.,
1984). This communication is a preliminary report
showing that the chemical is capable of inducing
intestinal tumours in rats following oral adminis-
tration.
Two groups of male ACI rats, two months old,
were used in this study. Rats of this strain have
been maintained as an inbred line at our
laboratory. Group I.-Eighteen rats were fed a
basal diet containing 1% chrysazin (JAPAN CLEA
Inc., Tokyo, Japan) throughout the experiment.
HO OH
Figure 1 Molecular structure of chrysazin.
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Chrysazin from Nakarai Chemicals Co. (Kyoto,
Japan) was pure. Group II.-Fifteen rats were fed
the basal diet without chrysazin and served as
controls. Diet and water (distilled water) were given
ad libitum and the experiment was terminated 16
months after the start of feeding. Animals were
inspected and weighed once every two weeks for the
initial two months, and once a month for the
subsequent duration of the experiment. They were
autopsied at death, when killed due to moribund
condition, or at the termination of the experiment.
Tissues were fixed in a 10% buffered formalin solu-
tion (pH7.4), sectioned, stained with hematoxylin
and eosin and examined histologically.
Rats of Group I consumed the diet containing
chrysazin as much as those of Group II (controls)
and gained weight in the same way as those of
Group II except 2 which died of diarrhoea and
anaemia within 3 months after the start of
experiment. Twelve rats of this group survived
more than 1 year. Of these, 7 rats developed
intestinal tumours of the colon or caecum (Table I).
They were pedunculated or sessile polyps and were
single except for two tumours which occurred in
one animal. Histologically, these intestinal tumours
were adenomas or adenocarcinomas (Figure 2;
Table I). Besides these neoplasms, focal hyper-
plastic lesions of the glandular epithelium of
the colon and caecum were frequently encountered
both in treated with and without intestinal tumours.
In the livers of several rats of this group, some
histological changes like focal necrosis, fibrosis,
cystic lesions and bile duct proliferation were seen.
In Group II, all rats except one which died of
pneumonia survived more than 1 year. They had no
intestinal tumours nor any pathological change in
any organ. Statistically, the incidence of intestinal
tumours of Group I was higher than that of Group
II (P<0.01).
Carcinogenic activities have been reported for
some derivatives of anthraquinones substituted with
amino (Grisword et al., 1968) or nitro groups
(Krishna-Murthy et al., 1977). Several anthra-
quinone-related compounds such as luteoskyrin
(Uraguchi et al., 1972) or (+)rugulosin (Ueno et
al., 1980) have been reported to be tumourigenic.
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Furthermore, anthraquinone-like anthralin is known
to have tumour-promoting effects (Segal et al.,
1971). However, no clear data showing carcino-
genicity of pure anthraquinones have yet been
reported. Thus, present results seem to be the first
evidence demonstrating carcinogenicity of pure
anthraquinone.
Figure 2 A well differentiated adenocarcinoma of the
colon in a rat of Group I. H & E ( x 42).
In this study, a number of rats given chrysazin
developed intestinal tumours. Furthermore, the
animals of this group had multifocal hyperplasia of
the mucosal epithelium of colon and caecum,
suggesting that multiple intestinal tumours at higher
incidence could have been induced if the animals
were able to survive for longer periods. Studying
spontaneous tumours in ACI rats, Maekawa &
Odashima (1975) found no tumours in the large
intestine. In addition, these intestinal tumours have
not yet been found in untreated rats of this strain
in overall long-term experiments performed in our
laboratory. Thus, the development of the intestinal
tumours in this study is caused by chrysazin
administration. Induction of large intestinal
tumours shown here suggests an organotropic
action of this chemical. Clear reasons for the
organotropism as well as the ultimate tumourigenic
form of this compound are not clear. But the
tumourigenicity of this chemical in the lower part
of the intestine may be related to the absorption of
the chemical by the intestine and excretion of the
metabolites to the intestine via bile (Brown, 1980).
Furthermore, it may be necessary to consider that
the gut flora could play a role in the activation of
chrysazin.
Several morphological changes indicating chronic
toxicity of this chemical were obtained in the livers
of rats given chrysazin, although no obvious liver
neoplasms were detected in them. Genotoxicity of
the chemical has been proved in rodent hepatocytes
(Mori et al., 1984). These data suggest the
possibility that chrysazin is hepatocarcinogenic.
Previously, Blair et al. (1977) reported foetal
explosure to 1,8-dihydroxyanthraquinone. Related
compounds of this chemical are widely distributed
in the genera of plants and fungi. Schmid (1952)
has reported that chrysazin can be converted to
anthrone by bacterial reduction. Accordingly, it
seems important to clarify the genotoxic and
carcinogenic properties of these anthraquinones.
Further experiments on the carcinogenicity of the
chemical using rats and other species are in
progress.
Table I Tumourigenicity of chrysazin in rats
No. ofrats with tumours of:
No. ofrats Colon Caecum
Effectivea with intestinal
Group rats No. ofrats tumours Adenoma Adenocarcinoma Adenoma
I 18 12 7 3(3) 4(4) 1(2)
(1% Chrysazin)
II 15 14 0 0 0 0
(Control)
aRats survived more than 1 year. Nos. in parentheses are total numbers of tumours.
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